FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2020369076> ?p ?o ?g. }

• W2020369076 endingPage "40" @default.
• W2020369076 startingPage "35" @default.
• W2020369076 abstract "Of about 20% of patients with relapsed/refractory Hodgkin lymphoma (HL), approximately half achieve long-term remissions after high-dose chemoradiotherapy and autologous stem cell transplantation (HDT/ASCT). Treatment with a comprehensive program using second-line chemotherapy with ICE (ifosfamide, carboplatin, etoposide) before HDT/ASCT identified a clinical prognostic model, but prognostic biologic markers in relapsed/refractory HL remain unclear. We sought to determine if we could identify such markers, and if our comprehensive second-line program could overcome their significance.Pre-ICE biopsy specimens of 191 patients enrolled on 1 of 2 Institutional Review Board-approved clinical trials of HDT/ASCT. We performed immunohistochemistry staining for Bcl-2, Bax, Bim, p53, and interleukin-6. Samples were considered positive if more than 10% of Hodgkin Reed-Sternberg cells stained at any intensity.Ninety-one patients had sufficient tissue available. Forty-eight patients (53%) had an event and 36 (40%) died. Median event-free survival (EFS) was 8.5 years, median overall survival (OS) was not reached, and median follow-up was 8.8 years. Bcl-2 was overexpressed in 37/91 (41%), Bax in 28/65 (43%), Bim in 9/72 (13%), p53 in 38/89 (43%), and interleukin-6 in 58/84 (69%) patients. Overexpression of these biomarkers had no statistically significant association with EFS or OS, except for association of Bim overexpression with inferior OS (P = 0.0385). The 3-factor clinical model (B symptoms at relapse, extranodal disease, and complete remission duration of < 1 y) remained highly significant (0/1 vs. 2/3 factors) for EFS and OS (P = 0.0008 and P = 0.0001, respectively).Despite the evidence that p53 and Bcl-2 overexpression may predict a worse prognosis with initial treatment, it seems that at relapse such overexpression is either not prognostically significant, or that the treatment with ICE and HDT/ASCT overcomes its significance. Subsequent studies should further address the role of Bim in both initial and relapsed/refractory settings." @default.
• W2020369076 created "2016-06-24" @default.
• W2020369076 creator A5001102192 @default.
• W2020369076 creator A5024940456 @default.
• W2020369076 creator A5047889637 @default.
• W2020369076 creator A5052897571 @default.
• W2020369076 creator A5071873190 @default.
• W2020369076 creator A5073861459 @default.
• W2020369076 date "2010-01-01" @default.
• W2020369076 modified "2023-10-05" @default.
• W2020369076 title "High Dose Chemoradiotherapy and ASCT May Overcome the Prognostic Importance of Biologic Markers in Relapsed/Refractory Hodgkin Lymphoma" @default.
• W2020369076 cites W1984976795 @default.
• W2020369076 cites W1990254666 @default.
• W2020369076 cites W2071518796 @default.
• W2020369076 cites W2080843369 @default.
• W2020369076 cites W2082758636 @default.
• W2020369076 cites W2087241613 @default.
• W2020369076 cites W2116177527 @default.
• W2020369076 cites W2122654415 @default.
• W2020369076 cites W2122658282 @default.
• W2020369076 cites W2122729126 @default.
• W2020369076 cites W2125707352 @default.
• W2020369076 cites W2135820233 @default.
• W2020369076 cites W2155925571 @default.
• W2020369076 cites W2157717016 @default.
• W2020369076 cites W2160578338 @default.
• W2020369076 cites W2161634387 @default.
• W2020369076 cites W2270424042 @default.
• W2020369076 cites W2313862504 @default.
• W2020369076 doi "https://doi.org/10.1097/pai.0b013e3181b473b7" @default.
• W2020369076 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19701081" @default.
• W2020369076 hasPublicationYear "2010" @default.
• W2020369076 type Work @default.
• W2020369076 sameAs 2020369076 @default.
• W2020369076 citedByCount "3" @default.
• W2020369076 countsByYear W20203690762012 @default.
• W2020369076 countsByYear W20203690762014 @default.
• W2020369076 countsByYear W20203690762021 @default.
• W2020369076 crossrefType "journal-article" @default.
• W2020369076 hasAuthorship W2020369076A5001102192 @default.
• W2020369076 hasAuthorship W2020369076A5024940456 @default.
• W2020369076 hasAuthorship W2020369076A5047889637 @default.
• W2020369076 hasAuthorship W2020369076A5052897571 @default.
• W2020369076 hasAuthorship W2020369076A5071873190 @default.
• W2020369076 hasAuthorship W2020369076A5073861459 @default.
• W2020369076 hasConcept C121332964 @default.
• W2020369076 hasConcept C126322002 @default.
• W2020369076 hasConcept C142424586 @default.
• W2020369076 hasConcept C143998085 @default.
• W2020369076 hasConcept C2776694085 @default.
• W2020369076 hasConcept C2777506904 @default.
• W2020369076 hasConcept C2778119113 @default.
• W2020369076 hasConcept C2778239845 @default.
• W2020369076 hasConcept C2778424827 @default.
• W2020369076 hasConcept C2779050716 @default.
• W2020369076 hasConcept C2779338263 @default.
• W2020369076 hasConcept C2780653079 @default.
• W2020369076 hasConcept C2781214270 @default.
• W2020369076 hasConcept C2781451048 @default.
• W2020369076 hasConcept C71924100 @default.
• W2020369076 hasConcept C87355193 @default.
• W2020369076 hasConcept C90924648 @default.
• W2020369076 hasConceptScore W2020369076C121332964 @default.
• W2020369076 hasConceptScore W2020369076C126322002 @default.
• W2020369076 hasConceptScore W2020369076C142424586 @default.
• W2020369076 hasConceptScore W2020369076C143998085 @default.
• W2020369076 hasConceptScore W2020369076C2776694085 @default.
• W2020369076 hasConceptScore W2020369076C2777506904 @default.
• W2020369076 hasConceptScore W2020369076C2778119113 @default.
• W2020369076 hasConceptScore W2020369076C2778239845 @default.
• W2020369076 hasConceptScore W2020369076C2778424827 @default.
• W2020369076 hasConceptScore W2020369076C2779050716 @default.
• W2020369076 hasConceptScore W2020369076C2779338263 @default.
• W2020369076 hasConceptScore W2020369076C2780653079 @default.
• W2020369076 hasConceptScore W2020369076C2781214270 @default.
• W2020369076 hasConceptScore W2020369076C2781451048 @default.
• W2020369076 hasConceptScore W2020369076C71924100 @default.
• W2020369076 hasConceptScore W2020369076C87355193 @default.
• W2020369076 hasConceptScore W2020369076C90924648 @default.
• W2020369076 hasIssue "1" @default.
• W2020369076 hasLocation W20203690761 @default.
• W2020369076 hasLocation W20203690762 @default.
• W2020369076 hasOpenAccess W2020369076 @default.
• W2020369076 hasPrimaryLocation W20203690761 @default.
• W2020369076 hasRelatedWork W2054697909 @default.
• W2020369076 hasRelatedWork W2073498983 @default.
• W2020369076 hasRelatedWork W2089800013 @default.
• W2020369076 hasRelatedWork W2147316169 @default.
• W2020369076 hasRelatedWork W239195424 @default.
• W2020369076 hasRelatedWork W2397845023 @default.
• W2020369076 hasRelatedWork W2414560200 @default.
• W2020369076 hasRelatedWork W2789166760 @default.
• W2020369076 hasRelatedWork W6933653 @default.
• W2020369076 hasRelatedWork W2133000900 @default.
• W2020369076 hasVolume "18" @default.
• W2020369076 isParatext "false" @default.
• W2020369076 isRetracted "false" @default.
• W2020369076 magId "2020369076" @default.

• next